212500-79-3

Upstream product

• 70461-33-5 2-bromo-4,5-dimethoxybenzaldehyde dimethyl acetal 
• 5658-49-1 N,N-dimethyl(3,4,5-trimethoxyphenyl)carboxamide 

Downstream Products

• 347423-76-1 methyl 2-[(4-tert-butoxycarbonylamino)phenyl]-1,2-dihydro-6,7-dimethoxy-1-oxo-4-(3,4,5-trimethoxyphenyl)-3-isoquinolinecarboxylate 
• 347423-74-9 2-(3-tert-butoxycarbonylamino-phenyl)-6,7-dimethoxy-1-oxo-4-(3,4,5-trimethoxy-phenyl)-1,2-dihydro-isoquinoline-3-carboxylic acid methyl ester 
• 260407-27-0 methyl 2-(4-benzyloxyphenyl)-1,2-dihydro-6,7-dimethoxy-1-oxo-4-(3,4,5-trimethoxyphenyl)-3-isoquinolinecarboxylate 
• 212489-68-4 6,7-dimethoxy-3-methoxycarbonyl-2-morpholino-4-(3,4,5-trimethoxyphenyl)-1(2H)-isoquinolinone 

Relevant academic research and scientific papers

Method of inhibiting neoplastic cells with isoquinoline derivatives

A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to isoquinoline derivatives.

Novel, potent, and selective phosphodiesterase 5 inhibitors: Synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivatives

A novel class of potent and selective phosphodiesterase 5 (PDE5) inhibitors, 4-aryl-1-isoquinolinone derivatives, which have been designed by the comparison of the structure of cGMP and a previously reported 1-arylnaphthalene lignan, was disclosed. Among